Thursday, November 20, 2025 4:09:06 PM
DD (you’re the real DD by the way, not danish dud) I agree with pretty much everything here but I don’t agree with the MHRA approval aspect.
I am confident MHRA can and will approve regardless of the manufacturing. I don’t guarantee it, but am confident nonetheless.
NICE is the issue, as that is the aspect of the process that considers cost of manufacturing. MHRA should be completely decoupled. Even if the cost is $10 million per dose, Northwest has manufacturing currently in place to produce it so MHRA can approve.
I think the approval delay is more related to NWBO intentionally stretching it out (and MHRA accommodating) because they all know NICE wont approve artisan.
I am confident MHRA can and will approve regardless of the manufacturing. I don’t guarantee it, but am confident nonetheless.
NICE is the issue, as that is the aspect of the process that considers cost of manufacturing. MHRA should be completely decoupled. Even if the cost is $10 million per dose, Northwest has manufacturing currently in place to produce it so MHRA can approve.
I think the approval delay is more related to NWBO intentionally stretching it out (and MHRA accommodating) because they all know NICE wont approve artisan.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
